Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis.

/in /da

Autore: Sophia Ehrstrom, Katalin Daroczy, Eva Rylander, Carolina Samuelsson, Ulrika Johannesson, Bo Anzen, Carl Pahlson

Anti-inflammatory effects of Vitamin D on human Immune cells

Potrebbero interessarti
Gastrointestinal symptoms before and during menses in healthy women
The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19
Dietary Lactoferrin Alleviates Age-Related Lacrimal Gland Dysfunction in Mice
Vaginal Microbiome and Epithelial Gene Array in Post- Menopausal Women with Moderate to Severe Dryness
Prevention of fungal vaginitis / bacterial vaginosis comparing two new devices: tampons releasing a LN® probiotic mix and tampons releasing chlorhexidine vs. neutral tampons (placebo). Open preliminary randomized prospective clinical trial
Effectiveness of oral administration of Lactobacillus paracasei subsp. paracasei F19 in conjunction with use of a vaginal tampon containing LN® probiotic mixture (L. gasseri LN40, L. fermentum LN99, L. casei subsp. rhamnosus LN113) in the treatment of vaginosis
Tear lactoferrin and lysozyme as clinically relevant biomarkers of mucosal immune competence
Antibacterial Activity of Lactoferrin and a Pepsin-Derived Lactoferrin Peptide Fragment